Oral chemotherapeutic agents have been available for many years, and were traditionally cytotoxic drugs, such as cyclophosphamide, methotrexate, and mercaptopurine. In recent years, oral anticancer medications are being used more often in many types of cancer.
Retrospective Analysis of Probiotic Effectiveness in Patients with Acute Myeloid Leukemia or Patients Undergoing Transplant Who Are Receiving Chemotherapy
It is well-known that patients with acute myeloid leukemia (AML) who receive induction and reinduction chemotherapy and any patients undergoing hematopoietic stem-cell transplant (HSCT) are at high risk for infections and prolonged hospital stays. Intensive chemotherapy regimens used in these settings cause patients to be neutropenic for prolonged durations.
Pain is one of the most feared symptoms of cancer, with uncontrolled pain being the most frequently reported symptom in hospitalized patients with cancer. As cancer stage progresses, the pain intensity and incidence increase, with cancer pain reported in 62% to 86% of patients with advanced disease.
Pharmacists are becoming increasingly involved in cancer care. This raises a vital question: How aware are pharmacy students of the expanding roles and opportunities in oncology pharmacy?
Comparing Oral Chemotherapy Safe Prescribing Practices in an Academic Health System: A Retrospective Analysis
The paradigm of oncology practice has changed significantly in recent years with the rapid emergence and use of oral chemotherapy agents.
Anastasia Finn, PharmD, MBA, BCOP, Jesse Young, PharmD, Kathy Edwards, PharmD, BCPS, BCOP, Andy Perez, PharmD, BCOP, Shawn MacVane, PharmD, BCPS
Treatment of Clostridium difficile infection presents a unique challenge in patients with cancer. C difficile infections are often related to the use of antibiotics and to hospitalizations, and patients undergoing chemotherapy treatment may be at a particularly high risk for infection.
Efficacy and Cost Analysis of a Plerixafor Protocol for Peripheral Blood Stem-Cell Mobilization in Patients with Multiple Myeloma or Non-Hodgkin Lymphoma
Autologous stem-cell transplantation (ASCT) extends overall survival for patients with multiple myeloma and is a potentially curative treatment option for patients with non-Hodgkin lymphoma (NHL).
The Effect of Written Pharmacist-Provided Patient Education for 3 Frequently Prescribed Oral Anticancer Agents on the Incidence of Patient-Initiated Triage Calls
Nicolas De Padova, PharmD, Robert Grabowski, PharmD, Joseph Ineck, PharmD, CPE, Robert Mancini, PharmD, BCOP
Oral chemotherapy agents (OCAs) continue to play an increasing role in the treatment and management of many oncologic diseases.
Justin Arnall, PharmD, discusses the clinical significance of his research and case study on, “Loss of Pregnancy in a Patient with Chronic Myeloid Leukemia During Treatment with Nilotinib.”
Determination of Extended Sterility for Single-Use Vials Using the PhaSeal Closed-System Transfer Device
Kristin V. Ho, PharmD, BCOP, Michael S. Edwards, PharmD, MBA, BCOP, Dominic A. Solimando, Jr, MA, BCOP, Anthony D. Johnson, CPhT
The use of closed-system transfer devices (CSTDs) for compounding hazardous medications has become an accepted standard of practice to minimize environmental exposure to these agents.
Page 1 of 4
Results 1 - 10 of 39
Results 1 - 10 of 39